Allergies News and Research

Latest Allergies News and Research

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

A study led by St. Jude Children's Research Hospital scientists highlights a new approach for developing a universal influenza vaccine that could protect against multiple flu strains, including deadly pandemic strains. The research appears today in the advance online edition of the scientific journal Nature Immunology.

22 Oct 2013

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Olodaterol is a long-acting beta2-agonist (LABA) bronchodilator delivered via the Respimat® inhaler. It is being investigated as a once daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

21 Oct 2013

Anergis reports immunology data from AllerT Phase IIb study for birch pollen allergy

Anergis, a company focusing on proprietary allergy vaccines, today reported immunology data from the Phase IIb study of its lead compound AllerT.

21 Oct 2013

Cytos Biotechnology enrolls patients in Phase 2b study of CYT003 for treatment of allergic asthma

Cytos Biotechnology Ltd ("Cytos" or the "Company") today announced that patient enrolment has been completed in the on-going phase 2b study with its lead product CYT003.

21 Oct 2013

Scientists find unexpected molecular switch that prompts blood stem cells aging

Scientists report in Nature they have found a novel and unexpected molecular switch that could become a key to slowing some of the ravages of getting older as it prompts blood stem cells to age.

21 Oct 2013

FEV1 poor mortality predictor in elderly

Research shows that forced expiratory volume in 1 second % predicted is ineffective for predicting mortality in elderly asthma patients.

18 Oct 2013

Inducing asthma control key to long-term outcomes

Patients with uncontrolled asthma should receive intensive management and follow-up, say researchers who found that good asthma control at one point in time is associated with increased likelihood for control over the subsequent year.

17 Oct 2013

Severe allergies in young people: an interview with Lynne Regent, CEO of Anaphylaxis Campaign

Around one third of the UK population – approximately 19 million people – will develop an allergy at some time in their lives. A significant proportion of these – around a million people – suffer severe symptoms.

17 Oct 2013

New discovery may lead to effective treatments for chronic itching

Anyone who has suffered through sleepless nights due to uncontrollable itching knows that not all itching is the same. New research at Washington University School of Medicine in St. Louis explains why.

16 Oct 2013

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

House dust mite allergy is a surprisingly prevalent problem. Something like 27% of the U.S. population and 20% of the European population are what’s called skin-prick test positive for house dust mites, which is a test for sensitivity to allergens to find out if a person is likely to get that allergy.

15 Oct 2013

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

Sanofi announced today that the U.S. Food and Drug Administration approved Nasacort Allergy 24HR nasal spray as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.

12 Oct 2013

New clinical trial shows increased asthma control with FeNO-guided anti-inflammatory treatment

A new randomised clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment.

11 Oct 2013

Maternal fatty acid intake linked to infant wheeze

Japanese researchers have found that high intake of certain fatty acids by pregnant women is associated with a lower risk for wheeze during infancy in their offspring.

10 Oct 2013

Halloween parties can heighten danger for kids with food allergies

The scary reality is that food allergies are becoming more and more common in the United States. In the past 10 years there has been an 18 percent increase in children with food allergies.

10 Oct 2013

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

New research published in the journal Nature Chemical Biology shows that a group of scientists, led by faculty at the University of Notre Dame, has made concrete progress toward the development of the first-ever inhibitory therapeutic for Type I hypersensitive allergic reactions.

10 Oct 2013

Asthma infection risk ‘goes beyond the airways’

Researchers from the USA have found that asthma may be associated with an increased risk for infections outside of the respiratory tract.

9 Oct 2013

FENO and B-Eos complement each other as asthma biomarkers

Research indicates that fraction of exhaled nitric oxide and blood eosinophil count values can independently predict asthma diagnosis and attacks.

8 Oct 2013

Smoking during pregnancy may affect child’s immune system on molecular level

The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.

8 Oct 2013

New picture of interaction between nervous & immune systems could lead to novel therapies

A new picture of how the nervous system interacts with the immune system to cause the itch and inflammation associated with eczema, a chronic skin disease, could lead to new therapies for the condition, according to University of California, Berkeley, scientists.

4 Oct 2013

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

Taking an important step toward the development of a product to prevent HIV infections associated with unprotected anal sex, researchers today announced the launch of a global Phase II clinical trial of a potential rectal microbicide.

3 Oct 2013

Allergies News and Research

Latest Allergies News and Research

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

Anergis reports immunology data from AllerT Phase IIb study for birch pollen allergy

Cytos Biotechnology enrolls patients in Phase 2b study of CYT003 for treatment of allergic asthma

Scientists find unexpected molecular switch that prompts blood stem cells aging

FEV1 poor mortality predictor in elderly

Inducing asthma control key to long-term outcomes

Severe allergies in young people: an interview with Lynne Regent, CEO of Anaphylaxis Campaign

New discovery may lead to effective treatments for chronic itching

House dust mite allergy treatment: an interview with Steve Harris, CEO & Co-founder of Circassia

Sanofi's Nasacort Allergy 24HR nasal spray receives FDA approval for over-the-counter use

New clinical trial shows increased asthma control with FeNO-guided anti-inflammatory treatment

Maternal fatty acid intake linked to infant wheeze

Halloween parties can heighten danger for kids with food allergies

Researchers made breakthrough development in inhibitory therapeutic for hypersensitive allergic reactions

Asthma infection risk ‘goes beyond the airways’

FENO and B-Eos complement each other as asthma biomarkers

Smoking during pregnancy may affect child’s immune system on molecular level

New picture of interaction between nervous & immune systems could lead to novel therapies

Researchers launch phase II clinical trial of rectal microbicide to prevent HIV infections

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in